ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
The purpose of this study is to evaluate the safety and efficacy of Pumitamig in combination with chemotherapy versus Nivolumab in combination with chemotherapy in participants with previously untreated advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma
Inclusion Criteria
Exclusion Criteria
Clinical.Trials@bms.com855-907-3286
Orange, California 92868, United States
Salem, Virginia 24153, United States
Madison, Wisconsin 53792, United States
Ciudad Autónoma de Buenos Aires, Buenos Aires C1414, Argentina
+5491162691673
Ciudad Autónoma de Buenos Aires, Buenos Aires C1426ANZ, Argentina
01132218900
ABB, Buenos Aires F.D. C1199ABB, Argentina
54111555960279
Buenos Aires, C1431FWO, Argentina
Belo Horizonte, Minas Gerais 30140-085, Brazil
Lyon Cedex08, Auvergne-Rhône-Alpes 69373, France
+33478785992
Nantes, Pays de la Loire Region 44093, France
Nashik, Dādra and Nagar Haveli and Damān and Diu 422001, India
Roma, 00168, Italy
Nagaizumi-cho,Sunto-gun, Shizuoka 411-8777, Japan
Chuo-ku, Tokyo 104-0045, Japan
81335422511
Koto-ku, Tokyo 135-8550, Japan
81335200111
Minami-Ku, Fukuoka, 811-1347, Japan
Warsaw, Masovian Voivodeship 02-034, Poland
Opole, Opole Voivodeship 45-061, Poland
Cluj-Napoca, Cluj 400162, Romania
Florești, Cluj 407280, Romania
40742206212
Seoul, Seoul-teukbyeolsi [Seoul] 03722, South Korea
Kadiköy/Istanbul, 41380, Turkey (Türkiye)
Sutton, Surrey SM2 5PT, United Kingdom
714-456-5153
239-274-9930
000-000-0000
813-745-4436
323-533-7275
646-888-4186
541-214-8284
503-528-5005
816-898-9413
615-986-4366
325-692-0188
512-427-9400
000-000-0000
713-792-2828
540-982-0237
608-265-9966
541158826679
+61752021111
0881829000
(03)95946666
0410582006
+61894389599
85999872264
5584991191032
351222055700
+551733216638
4169464501ext.2520
13911219511
8613509339525
8613925106525
13457161928
8613310167477
33298223428
+33320445461
33240083163
33549444951
33156095064
+4930450657306
496976014187
494036035220
4962215637630
496131176076
+496213832488
4973150044500
390815666713
390498215910
390223903807
+390226437615
390458128116
81527626111
81471331111
81668795111
225709223
48227661500
48502313767
48502051990
+40724251696
40727774974
40745646368
40746110096
40766307558
821041671676
82220720701
82222288050
82230105935
+82-2-3410-6820
+34654557483
0034848422222
+34961973517
34914269519
34620944068
34917277516
34951291425
07985955179
441223216083
00447779272168
00447779272168
447710630514